Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)

China flag China · Delayed Price · Currency is CNY
8.46
-0.25 (-2.87%)
May 30, 2025, 2:45 PM CST
63.95%
Market Cap 3.50B
Revenue (ttm) 180.64M
Net Income (ttm) -86.96M
Shares Out 414.69M
EPS (ttm) -0.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 23,619,852
Average Volume 32,423,121
Open 8.50
Previous Close 8.71
Day's Range 8.38 - 8.76
52-Week Range 4.00 - 40.98
Beta 0.36
RSI 49.43
Earnings Date Aug 28, 2025

About SHE:002693

Hainan Shuangcheng Pharmaceuticals Co., Ltd. provides peptide, lyophilized, oncology, oral dosage, and other injection cartridge pharmaceutical products worldwide. The company offers thymalfasin, thymapentin, bortezmib, paclitaxel, somatostatin, pantoprazole, epifibatide, bivalirudin, liraglutide, and exenatide and sodium ferulate for injections, as well as vitamin B6. Hainan Shuangcheng Pharmaceuticals Co., Ltd. was founded in 2000 and is based in Haikou, the People’s Republic of China. [Read more]

Sector Healthcare
Founded 2000
Employees 474
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002693
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.